Covered recipient · General Payments record
GRETCHEN LYNN GARLAND
Allopathic & Osteopathic Physicians Pediatrics
General Payments · PY2022–2024
$372.06
- Reported across 22 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $183.40 | 11 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| GlaxoSmithKline, LLC. | $52.84 | 3 |
| ABBVIE INC. | $36.87 | 2 |
| Amgen Inc. | $29.21 | 2 |
| Abbott Laboratories | $18.44 | 1 |
| Lilly USA, LLC | $17.07 | 1 |
| Novo Nordisk AS | $14.68 | 1 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $14.29 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $18.44 | 09/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124824537 | CMS |
| ABBVIE INC. | $22.53 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103777115 | CMS |
| ABBVIE INC. | $14.34 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103777117 | CMS |
| Amgen Inc. | $15.57 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117257921 | CMS |
| Amgen Inc. | $13.64 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117257923 | CMS |
| GlaxoSmithKline, LLC. | $22.83 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116243405 | CMS |
| GlaxoSmithKline, LLC. | $16.94 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116538484 | CMS |
| GlaxoSmithKline, LLC. | $13.07 | 07/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116375070 | CMS |
| Lilly USA, LLC | $17.07 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134979180 | CMS |
| Novo Nordisk Inc | $14.68 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097483671 | CMS |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $14.29 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153742248 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.